PG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operational Performance Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip PRCT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment CL Q1 2026 Earnings Slight EPS Miss Amid Steady Performance TECH Q1 2026 Earnings EPS Misses Estimates Amid Mixed Demand Signals CMDB Q1 2026 Earnings Positive EPS Amid Quiet Market Reaction DSGN Q1 2026 Earnings EPS Beats Estimates as Development Stage Biotech Advances Pipeline UFI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction TFII Q1 2026 Earnings EPS Beats Estimates by Double Digits LXFR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction BK Q1 2026 Earnings Strong EPS Beat Highlights Resilient Fee Income and Cost Discipline Stem Inc Q1 2026 Earnings EPS Beat Drives Stock Higher Despite Challenging Operating Environment